Clinical Trials in San Francisco

Showing 5181-5200 of 9,883 trials

COMPLETEDPhase 2< 1 mile

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

NCT02395978

The purpose of this study is to evaluate the safety and efficacy in patients with major depressive disorder.

Major Depressive Disorder

BioLite, Inc.72 participantsStarted Apr 2015

San Francisco, California, United States • Taipei, Taiwan • Taipei, Taiwan +2 more locations

SUSPENDEDNA< 1 mile

Improving Palliative Care Access Through Technology

NCT04969484

This project will focus on developing, optimizing and pilot-testing a multi-component Improving Access Through Technology (ImPAcTT) intervention that leverages existing telehealth technologies to provide staff education; family outreach, engagement and support; care coordination; and resident symptom management and facilitation of goals-of-care discussion.

TelehealthPalliative Care

University of Utah81 participantsStarted Feb 2018

San Francisco, California, United States • Salt Lake City, Utah, United States

COMPLETEDNA< 1 mile

Effects of Sleep Duration and Architecture on Insulin Sensitivity

NCT01396941

This pilot clinical trial will test the hypotheses that sleep restriction (for 5 nights), in comparison to "normal sleep", will: 1. Decrease peripheral insulin sensitivity and glucose tolerance, as measured by the hyperinsulinemic-euglycemic clamp and oral glucose tolerance test. 2. Decrease hepatic insulin sensitivity, as assessed by stable isotope studies of endogenous glucose production, gluconeogenesis and glycogenolysis.

Insulin Resistance

University of California, San Francisco10 participantsStarted May 2011

San Francisco, California, United States

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Improving Palliative Care Access Through Technology

Effects of Sleep Duration and Architecture on Insulin Sensitivity

Find Trials by Condition in San Francisco

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload